Luisa Gregori

2.9k total citations
54 papers, 2.4k citations indexed

About

Luisa Gregori is a scholar working on Molecular Biology, Physiology and Cell Biology. According to data from OpenAlex, Luisa Gregori has authored 54 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 9 papers in Physiology and 7 papers in Cell Biology. Recurrent topics in Luisa Gregori's work include Prion Diseases and Protein Misfolding (34 papers), Ubiquitin and proteasome pathways (10 papers) and Alzheimer's disease research and treatments (8 papers). Luisa Gregori is often cited by papers focused on Prion Diseases and Protein Misfolding (34 papers), Ubiquitin and proteasome pathways (10 papers) and Alzheimer's disease research and treatments (8 papers). Luisa Gregori collaborates with scholars based in United States, United Kingdom and Netherlands. Luisa Gregori's co-authors include Maria E. Figueiredo‐Pereira, Dmitry Goldgaber, Alexandra Alves‐Rodrigues, Vincent Chau, Robert G. Rohwer, A. L. Schwarzman, Warren J. Strittmatter, Michael P. Vitek, R Bhasin and Chana Fuchs and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Luisa Gregori

54 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luisa Gregori United States 23 1.8k 665 473 220 218 54 2.4k
Simona Paladino Italy 34 1.9k 1.0× 532 0.8× 871 1.8× 157 0.7× 286 1.3× 80 2.9k
Sergio Marchesini Italy 23 1.6k 0.9× 836 1.3× 477 1.0× 202 0.9× 102 0.5× 53 2.5k
Daniela Sarnataro Italy 27 1.5k 0.8× 415 0.6× 450 1.0× 158 0.7× 145 0.7× 56 2.2k
Caoimhín G. Concannon Ireland 29 2.1k 1.1× 372 0.6× 536 1.1× 351 1.6× 244 1.1× 48 2.9k
Haipeng Cheng China 27 1.3k 0.7× 688 1.0× 395 0.8× 224 1.0× 207 0.9× 71 2.3k
Anna Filipek Poland 31 2.0k 1.1× 392 0.6× 292 0.6× 248 1.1× 227 1.0× 99 2.8k
David A. Lomas United Kingdom 22 1.2k 0.6× 777 1.2× 525 1.1× 178 0.8× 402 1.8× 32 2.6k
François G. Gervais Canada 21 1.5k 0.8× 779 1.2× 287 0.6× 448 2.0× 327 1.5× 30 2.8k
Adele Cooney United States 19 976 0.5× 828 1.2× 479 1.0× 169 0.8× 304 1.4× 25 2.1k
David A. Priestman United Kingdom 26 1.1k 0.6× 1.0k 1.5× 492 1.0× 215 1.0× 155 0.7× 58 2.2k

Countries citing papers authored by Luisa Gregori

Since Specialization
Citations

This map shows the geographic impact of Luisa Gregori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luisa Gregori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luisa Gregori more than expected).

Fields of papers citing papers by Luisa Gregori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luisa Gregori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luisa Gregori. The network helps show where Luisa Gregori may publish in the future.

Co-authorship network of co-authors of Luisa Gregori

This figure shows the co-authorship network connecting the top 25 collaborators of Luisa Gregori. A scholar is included among the top collaborators of Luisa Gregori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luisa Gregori. Luisa Gregori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bett, Cyrus, et al.. (2020). Processing bovine intestinal mucosa to active heparin removes spiked BSE agent. Biologicals. 67. 56–61. 5 indexed citations
3.
Asher, David M. & Luisa Gregori. (2018). Human transmissible spongiform encephalopathies: historic view. Handbook of clinical neurology. 153. 1–17. 22 indexed citations
4.
Bett, Cyrus, et al.. (2017). A Heparin Purification Process Removes Spiked Transmissible Spongiform Encephalopathy Agent. The AAPS Journal. 19(3). 765–771. 15 indexed citations
5.
Nemecek, Julie, Christina M. Carlson, Dennis M. Heisey, et al.. (2013). Red-Backed Vole Brain Promotes Highly Efficient In Vitro Amplification of Abnormal Prion Protein from Macaque and Human Brains Infected with Variant Creutzfeldt-Jakob Disease Agent. PLoS ONE. 8(10). e78710–e78710. 7 indexed citations
6.
Bannach, Oliver, Eva Birkmann, Elke Reinartz, et al.. (2012). Detection of Prion Protein Particles in Blood Plasma of Scrapie Infected Sheep. PLoS ONE. 7(5). e36620–e36620. 34 indexed citations
7.
Gregori, Luisa, Gábor G. Kovács, Irina Alexeeva, Herbert Budka, & Robert G. Rohwer. (2008). Excretion of Transmissible Spongiform Encephalopathy Infectivity in Urine. Emerging infectious diseases. 14(9). 1406–1412. 33 indexed citations
8.
Gregori, Luisa, et al.. (2008). A sensitive and quantitative assay for normal PrP in plasma. Journal of Virological Methods. 149(2). 251–259. 13 indexed citations
9.
Gregori, Luisa, Patrick V. Gurgel, Liliana Gheorghiu, et al.. (2006). Reduction of transmissible spongiform encephalopathy infectivity from human red blood cells with prion protein affinity ligands. Transfusion. 46(7). 1152–1161. 55 indexed citations
10.
Schwarzman, A. L., Maria Tsiper, Luisa Gregori, et al.. (2005). Selection of peptides binding to the amyloid b-protein reveals potential inhibitors of amyloid formation. Amyloid. 12(4). 199–209. 18 indexed citations
11.
Minor, Philip D., C. Bergeron, Luisa Gregori, et al.. (2004). Standards for the assay of Creutzfeldt–Jakob disease specimens. Journal of General Virology. 85(6). 1777–1784. 34 indexed citations
12.
Gregori, Luisa, et al.. (2003). Partitioning of TSE infectivity during ethanol fractionation of human plasma. Biologicals. 32(1). 1–10. 44 indexed citations
13.
Dranovsky, Alex, Inez Vincent, Luisa Gregori, et al.. (2001). Cdc2 phosphorylation of nucleolin demarcates mitotic stages and Alzheimer’s disease pathology. Neurobiology of Aging. 22(4). 517–528. 73 indexed citations
14.
Gregori, Luisa, et al.. (2000). Ubiquitination and Degradation of the Zebrafish Paired‐Like Homeobox Protein Vsx‐1. Journal of Neurochemistry. 75(1). 48–55. 13 indexed citations
15.
Alves‐Rodrigues, Alexandra, Luisa Gregori, & Maria E. Figueiredo‐Pereira. (1998). Ubiquitin, cellular inclusions and their role in neurodegeneration. Trends in Neurosciences. 21(12). 516–520. 320 indexed citations
16.
Gregori, Luisa, James F. Hainfeld, Martha N. Simon, & Dmitry Goldgaber. (1997). Binding of Amyloid β Protein to the 20 S Proteasome. Journal of Biological Chemistry. 272(1). 58–62. 128 indexed citations
17.
Gregori, Luisa, Chana Fuchs, Maria E. Figueiredo‐Pereira, William E. Van Nostrand, & Dmitry Goldgaber. (1995). Amyloid β-Protein Inhibits Ubiquitin-dependent Protein Degradation in Vitro. Journal of Biological Chemistry. 270(34). 19702–19708. 202 indexed citations
18.
Gregori, Luisa, R Bhasin, & Dmitry Goldgaber. (1994). Ubiquitin-Mediated Degradative Pathway Degrades the Extracellular but Not the Intracellular Form of Amyloid β-Protein Precursor. Biochemical and Biophysical Research Communications. 203(3). 1731–1738. 11 indexed citations
19.
Goldgaber, Dmitry, R Bhasin, Luisa Gregori, et al.. (1993). Sequestration of Amyloid β‐Peptidea. Annals of the New York Academy of Sciences. 695(1). 139–143. 27 indexed citations
20.
Ruggieri, Silverio, et al.. (1988). Recent observations on the structure and the properties of yeast NMN adenylyltransferase. Cellular and Molecular Life Sciences. 44(1). 27–29. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026